We’re pleased to announce that we’ve released our 2025 whitepaper1 which looks in-depth at the growing impact of rising cancer rates on multinational employers and insurers.
The whitepaper uses our global claims data, drawn from standardised, anonymised data from millions of claimants around the world, to provide practical strategies for addressing claims trends.2
Cancer is a topic that has dominated discussions in the global health space in recent years. The surge in cases has placed unprecedented strain on healthcare systems all over the world and presents a profound challenge for multinational employers and insurers.
Our data shows cancer incidence was 155% higher in 2024 when compared to the average of 2017-2019, with the associated costs rising by a staggering 234% in the same period. Perhaps most shocking of all is the average age of claimants, which has dropped to 40 years of age in 2024, down from 47 across the 2017-2019 period.
The whitepaper looks at a wide range of topics related to cancer, including the most-common pre-existing conditions that show before a cancer diagnosis, the industries that most often correlate with certain cancer types and the impact of missed cancer screenings.
What can multinationals and insurers do?
This whitepaper doesn’t aim to simply present findings and highlight problems. Instead, it offers practical solutions for both multinational employers and insurers, aiming to help them optimise, innovate and lead in the cancer space.
We hope these insights can help multinationals truly care for their people and address this crisis head on.
Dr Leena Johns, Chief Health & Wellness Officer, MAXIS GBN, authored the whitepaper. She said: “Cancer is something that impacts us all, whether directly or through our loved ones, and for this reason it can be a difficult topic to discuss. But it’s also the scale of its impact that means it vital that we do talk about it.
“I knew that that cancer had to be the focus of our 2025 whitepaper because the disturbing story being told by our data revealed the urgency of this crisis. I wanted to provide a clear snapshot of the cancer crisis and share real, actionable strategies and solutions for multinationals and insurers.
“This is a huge topic and the insights can be daunting, but there is hope. I truly believe that employers and insurers should feel empowered to take action: they are at the forefront of this crisis and are in a unique position to drive meaningful change, ultimately leading to happier, healthier and more productive workforces.”
The full whitepaper can be downloaded here
1 The full whitepaper is available for download at maxis-gbn.com/cancer.
2 MAXIS’ medical claims data refers to the private medical claims paid by our network of insurers in more than 40 countries around the world (not including the US), covering more than 1.3 million lives. The countries included in our claims data analysis are: Bahrain, Belgium, Canada, Chile, Colombia, Costa Rica, Cyprus, Ecuador, Egypt, El Salvador, Greece, Guatemala, Honduras, Peru, Hong Kong, Indonesia, Jordan, Kuwait, Lebanon, Malaysia, Mexico, Nicaragua, Oman, Pakistan, Panama, Philippines, Qatar, Singapore, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates (UAE), United Kingdom (UK) and Vietnam.
For media enquiries please contact
Kate Ross / Nick Spearing
MAXIS Global Benefits Network – [email protected]
This document has been prepared by MAXIS GBN S.A.S. and is for informational purposes only – it does not constitute advice. MAXIS GBN S.A.S. has made every effort to ensure that the information contained in this document has been obtained from reliable sources but cannot guarantee accuracy or completeness. The information contained in this document may be subject to change at any time without notice. Any reliance you place on this information is therefore strictly at your own risk.
Not all services are available from all MAXIS member insurance companies or to all clients. The services are subject to local market practices, and compliance with all applicable legal and regulatory requirements.
About MAXIS GBN
MAXIS Global Benefits Network (MAXIS GBN), co-founded by MetLife and AXA in 1998 is one of the leading international employee benefits networks providing global service capabilities and delivering world-class employee benefits perspectives and solutions to clients in over 100 markets around the world. In February 2016, MetLife and AXA further strengthened their relationship by combining all of its MAXIS GBN existing operations under a joint venture company. This transformation helps leverage the existing strength of the network and its two parent companies while further enhancing the client experience, focusing on product innovation and providing data analytics. For more information, please visit www.maxis-gbn.com.
The MAXIS Global Benefits Network (“Network”) is a network of locally licensed MAXIS member insurance companies (“Members”) founded by AXA France Vie, Paris, France (“AXA”) and Metropolitan Life Insurance Company, New York, NY (“MLIC”). MAXIS GBN S.A.S, a Private Limited Company with a share capital of €4,650,000, registered with ORIAS under number 16000513, and with its registered office at 313, Terrasses de l’Arche – 92727 Nanterre Cedex, France, is an insurance and reinsurance intermediary that promotes the Network. MAXIS GBN S.A.S is jointly owned by affiliates of AXA and MLIC and does not issue policies or provide insurance; such activities are carried out by the Members. MAXIS GBN S.A.S operates in the UK through its UK establishment with its registered address at 1st Floor, The Monument Building, 11 Monument Street, London EC3R 8AF, Establishment Number BR018216 and in other European countries on a services basis. MAXIS GBN S.A.S operates in the U.S. through MAXIS Insurance Brokerage Services, Inc., with its registered office located in New York, USA, a New York licensed insurance broker. MLIC and Delaware American Life Insurance Company are the only Members licensed to transact insurance business in New York. The other Members are not licensed or authorised to do business in New York and the policies and contracts they issue have not been approved by the New York Superintendent of Financial Services, are not protected by the New York state guaranty fund, and are not subject to all of the laws of New York.